Veritas In Silico is a biotech company developing novel medicines targeting messenger RNA (mRNA) using its proprietary AI-powered drug discovery platform 'aibVIS', which combines in silico RNA structural analysis with experimental biology. The company operates a platform business model, partnering with major pharmaceutical companies including Shionogi, Toray, and Mitsubishi Gas Chemical to co-develop mRNA-targeting small molecule drugs, while also advancing its own proprietary pipeline focused on nucleic acid medicines for rare diseases. Its innovative drug delivery system 'Perfusio' further strengthens the pipeline by addressing delivery challenges unique to nucleic acid therapeutics.
Free demo (no time limit, up to 10 companies). Explore Comps, DCF, LBO, WACC on every screen. Excel export is on the paid plan.
Free Demo (No Time Limit, 10 Companies) →Veritas In Silico is a biotech company developing novel medicines targeting messenger RNA (mRNA) using its proprietary AI-powered drug discovery platform 'aibVIS', which combines in silico RNA structural analysis with experimental biology. The company operates a platform business model, partnering with major pharmaceutical companies including Shionogi, Toray, and Mitsubishi Gas Chemical to co-develop mRNA-targeting small molecule drugs, while also advancing its own proprietary pipeline focused on nucleic acid medicines for rare diseases. Its innovative drug delivery system 'Perfusio' further strengthens the pipeline by addressing delivery challenges unique to nucleic acid therapeutics.
Free demo (no time limit, up to 10 companies). Explore Comps, DCF, LBO, WACC on every screen. Excel export is on the paid plan.
Free Demo (No Time Limit, 10 Companies) →